Vir stock catapulted late Monday after the small biotech company smashed fourth-quarter sales views and signed a deal with Astellas Pharma.
Vir Biotech Catapults 65% On A $1.71 Billion Deal With Astellas Investor's Business Daily.
Hence then, the article about vir biotech catapults 65 on a 1 71 billion deal with astellas was published today ( ) and is available on IBD ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Vir Biotech Catapults 65% On A $1.71 Billion Deal With Astellas )
Also on site :
- Certis and FieldAI Form Strategic Partnership to Deploy Autonomous Robotics in Real-World Security Operations
- Peter Mandelson arrest latest: Peer released on bail as Epstein accuser Virginia Giuffre’s family issues statement
- Discord cuts ties with Peter Thiel-backed verification software after its code was found tied to U.S. surveillance efforts